Even though the medical relevance of the aforementioned cardiovascular hazard factor alterations by tirzepatide will be assessed from the prepared cardiovascular outcome analyze SURPASS-CVOT ( "variety":"clinical-trial","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Investigation indicated that tirzepatide didn't rais... https://research-chemicals87430.blogzet.com/details-fiction-and-chemical-research-in-toxicology-42822381